UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR

Molecular cancer therapeutics, 2017-08, Vol.16 (8), p.1470-1486

2017

Volltextzugriff (PDF)

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

Scientific reports, 2017-11, Vol.7 (1), p.14674-17, Article 14674

2017

Volltextzugriff (PDF)

Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges

Journal of nanomaterials, 2013-01, Vol.2013 (1)

2013

Volltextzugriff (PDF)

Exosomes in diagnostic and therapeutic applications of ovarian cancer

Journal of ovarian research, 2024-05, Vol.17 (1), p.113-113, Article 113

2024

Volltextzugriff (PDF)

Histone Deacetylase Inhibitors Radiosensitize Human Melanoma Cells by Suppressing DNA Repair Activity

Clinical cancer research, 2005-07, Vol.11 (13), p.4912-4922

2005

Volltextzugriff (PDF)

Gefitinib Radiosensitizes Non–Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

Clinical cancer research, 2008-02, Vol.14 (4), p.1266-1273

2008

Volltextzugriff (PDF)

Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci

Molecular cancer therapeutics, 2006-08, Vol.5 (8), p.1967-1974

2006

Volltextzugriff (PDF)

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells

Cancers, 2021-01, Vol.13 (2), p.166

2021

Volltextzugriff (PDF)

Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment

Seminars in cancer biology, 2022-11, Vol.86 (Pt 1), p.80-100

2022

Volltextzugriff (PDF)

Mitogen-activated protein kinases and their role in radiation response

Genes & cancer, 2013-09, Vol.4 (9-10), p.401-408

2013

Volltextzugriff (PDF)

RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer

Advanced drug delivery reviews, 2022-12, Vol.191, p.114569-114569, Article 114569

2022

Volltextzugriff (PDF)

Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer

Advanced drug delivery reviews, 2021-11, Vol.178, p.113918-113918, Article 113918

2021

Volltextzugriff (PDF)

Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems

Drug development and industrial pharmacy, 2017-09, Vol.43 (9), p.1391-1401

2017

Volltextzugriff (PDF)

Impact of HR Policies on Gender Inclusion in Indian Army: An Empirical Study

South Asian Journal of Human Resource Management, 2019-06, Vol.6 (1), p.9-28

Munshi, Anupama

2019

Volltextzugriff (PDF)

Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery

Advances in cancer research, 2018-01, Vol.137, p.115-170

2018

Volltextzugriff (PDF)

Tumor-targeted exosomes for delivery of anticancer drugs

Cancer letters, 2023-04, Vol.558, p.216093-216093, Article 216093

2023

Volltextzugriff (PDF)

Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy

The AAPS journal, 2021-02, Vol.23 (2), p.30-30, Article 30

2021

Volltextzugriff (PDF)

Interleukin (IL)-24: Reconfiguring the Tumor Microenvironment for Eliciting Antitumor Response

Advances in experimental medicine and biology, 2021-01, Vol.1290, p.99-110

2021

Volltextzugriff (PDF)

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs

Cancer letters, 2020-08, Vol.486, p.18-28

2020

Volltextzugriff (PDF)

TRAIL (APO-2l) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2

Oncogene, 2001-06, Vol.20 (29), p.3757-3765

2001

Volltextzugriff (PDF)

Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage

International journal of radiation biology, 2021-08, Vol.97 (8), p.1109-1120

2021

Volltextzugriff (PDF)

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Topics in current chemistry (2016), 2017-04, Vol.375 (2), Article 35

2017

Volltextzugriff (PDF)

Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment

Nanomedicine, 2018-02, Vol.14 (2), p.373-384

2018

Volltextzugriff (PDF)

Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells

Molecular cancer therapeutics, 2004-08, Vol.3 (8), p.985-992

2004

Volltextzugriff (PDF)

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Scientific reports, 2016-12, Vol.6 (1), p.38541, Article 38541

2016

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(97)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(57)
Humans
(46)
Oncology
(35)
Cell Line, Tumor
(24)
Lung Cancer
(20)
Apoptosis
(18)
Cancer
(15)
Animals
(14)
Biological And Medical Sciences
(12)
Nanoparticles
(12)
Proteins
(12)
Science & Technology - Other Topics
(12)
Drug Delivery
(11)
Dna Damage
(10)
Drug Delivery Systems
(10)
Female
(10)
Medical Sciences
(10)
Pharmacology & Pharmacy
(10)
Radiation
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges

Exosomes in diagnostic and therapeutic applications of ovarian cancer

Histone Deacetylase Inhibitors Radiosensitize Human Melanoma Cells by Suppressing DNA Repair Activity

Gefitinib Radiosensitizes Non–Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells

Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment

Mitogen-activated protein kinases and their role in radiation response

RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer

Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer

Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems

Impact of HR Policies on Gender Inclusion in Indian Army: An Empirical Study

Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery

Tumor-targeted exosomes for delivery of anticancer drugs

Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy

Interleukin (IL)-24: Reconfiguring the Tumor Microenvironment for Eliciting Antitumor Response

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs

TRAIL (APO-2l) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2

Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment

Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Suchergebnisse filtern